⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Official Title: A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER)

Study ID: NCT02817633

Conditions

Neoplasms

Study Description

Brief Summary: This is a first-in-human study evaluating the anti-T cell immunoglobulin and mucin containing protein-3 (TIM-3) antibody TSR-022. The study will be conducted in 2 parts with Part 1 consisting of dose escalation and Part 2 dose expansion. Part 1 will determine the recommended Phase 2 dose (RP2D) of TSR-022 and Part 2 will evaluate the antitumor activity of TSR-022 in combination with TSR-042 or docetaxel and as monotherapy.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

GSK Investigational Site, Goodyear, Arizona, United States

GSK Investigational Site, Scottsdale, Arizona, United States

GSK Investigational Site, Tucson, Arizona, United States

GSK Investigational Site, Tucson, Arizona, United States

GSK Investigational Site, Encinitas, California, United States

GSK Investigational Site, Fountain Valley, California, United States

GSK Investigational Site, Los Angeles, California, United States

GSK Investigational Site, Los Angeles, California, United States

GSK Investigational Site, Whittier, California, United States

GSK Investigational Site, Aurora, Colorado, United States

GSK Investigational Site, Aurora, Colorado, United States

GSK Investigational Site, Denver, Colorado, United States

GSK Investigational Site, Denver, Colorado, United States

GSK Investigational Site, New Haven, Connecticut, United States

GSK Investigational Site, Washington, District of Columbia, United States

GSK Investigational Site, Jacksonville, Florida, United States

GSK Investigational Site, Miami Beach, Florida, United States

GSK Investigational Site, Sarasota, Florida, United States

GSK Investigational Site, Tampa, Florida, United States

GSK Investigational Site, Atlanta, Georgia, United States

GSK Investigational Site, Augusta, Georgia, United States

GSK Investigational Site, Arlington Heights, Illinois, United States

GSK Investigational Site, Chicago, Illinois, United States

GSK Investigational Site, Niles, Illinois, United States

GSK Investigational Site, Iowa City, Iowa, United States

GSK Investigational Site, Wichita, Kansas, United States

GSK Investigational Site, Louisville, Kentucky, United States

GSK Investigational Site, Pikeville, Kentucky, United States

GSK Investigational Site, Rockville, Maryland, United States

GSK Investigational Site, Boston, Massachusetts, United States

GSK Investigational Site, Detroit, Michigan, United States

GSK Investigational Site, Rochester, Minnesota, United States

GSK Investigational Site, Hackensack, New Jersey, United States

GSK Investigational Site, Bronx, New York, United States

GSK Investigational Site, New York, New York, United States

GSK Investigational Site, Cincinnati, Ohio, United States

GSK Investigational Site, Cleveland, Ohio, United States

GSK Investigational Site, Toledo, Ohio, United States

GSK Investigational Site, Eugene, Oregon, United States

GSK Investigational Site, Portland, Oregon, United States

GSK Investigational Site, Bethlehem, Pennsylvania, United States

GSK Investigational Site, Pittsburgh, Pennsylvania, United States

GSK Investigational Site, Charleston, South Carolina, United States

GSK Investigational Site, Greenville, South Carolina, United States

GSK Investigational Site, Nashville, Tennessee, United States

GSK Investigational Site, Austin, Texas, United States

GSK Investigational Site, Dallas, Texas, United States

GSK Investigational Site, Fort Worth, Texas, United States

GSK Investigational Site, Houston, Texas, United States

GSK Investigational Site, Houston, Texas, United States

GSK Investigational Site, Longview, Texas, United States

GSK Investigational Site, McAllen, Texas, United States

GSK Investigational Site, San Antonio, Texas, United States

GSK Investigational Site, San Marcos, Texas, United States

GSK Investigational Site, Temple, Texas, United States

GSK Investigational Site, Tyler, Texas, United States

GSK Investigational Site, Weslaco, Texas, United States

GSK Investigational Site, Fairfax, Virginia, United States

GSK Investigational Site, Kennewick, Washington, United States

GSK Investigational Site, Puyallup, Washington, United States

GSK Investigational Site, Tacoma, Washington, United States

GSK Investigational Site, Madison, Wisconsin, United States

GSK Investigational Site, Daegu, , Korea, Republic of

GSK Investigational Site, Seongnam-si, Gyeonggi-do, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Palma de Mallorca, Islas Baleares, Spain

GSK Investigational Site, Madrid, Navarra, Spain

GSK Investigational Site, Barcelona, , Spain

GSK Investigational Site, Barcelona, , Spain

GSK Investigational Site, Girona, , Spain

GSK Investigational Site, Jerez de la Frontera, , Spain

GSK Investigational Site, L'Hospitalet De Llobregat, , Spain

GSK Investigational Site, Las Palmas De Gran Canaria, , Spain

GSK Investigational Site, Madrid, , Spain

GSK Investigational Site, Madrid, , Spain

GSK Investigational Site, Madrid, , Spain

GSK Investigational Site, Majadahonda (Madrid), , Spain

GSK Investigational Site, Málaga, , Spain

GSK Investigational Site, Pamplona, , Spain

GSK Investigational Site, Santander, , Spain

GSK Investigational Site, Sevilla, , Spain

GSK Investigational Site, Valencia, , Spain

GSK Investigational Site, Valencia, , Spain

Contact Details

Name: GSK Clinical Trials

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: